HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure

Despite the availability of effective vaccines and antiviral therapy over the past two to three decades, chronic hepatitis B virus (HBV) infection remains a major global health threat as a leading cause of cirrhosis and liver cancer. Functional HBV cure defined as hepatitis B surface antigen (HBsAg)...

Descripción completa

Detalles Bibliográficos
Autores principales: Moini, Maryam, Fung, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029793/
https://www.ncbi.nlm.nih.gov/pubmed/35458387
http://dx.doi.org/10.3390/v14040657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029793/
https://www.ncbi.nlm.nih.gov/pubmed/35458387
http://dx.doi.org/10.3390/v14040657

Ejemplares similares